Search Results 1631-1640 of 17851 for Substance+dependence
Mayo Clinic psychiatrists and psychologists are leaders in the clinical care of mental illnesses in people of all ages. They tailor their care to your exact ...
... drug. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
The laboratory has observed that lipotoxic hepatocytes, through a mixed lineage kinase 3 (MLK3)-dependent mechanism, release CXCL10-enriched chemotactic ...
... drug, AND must also adhere to the guidelines of any treatment-specific ... Agree to practice effective barrier contraception during the entire study treatment ...
The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio ...
... drug is approved, the participant withdraws from the study, or the study is terminated. New patients will be trained to use the nebuliser at the first ...
... substance, whichever is longer) before randomization;. • Concomitant use of combined P-gp and strong CYP3A4 inhibitors e.g. human immunodeficiency virus ...
Dosing with any investigational drug or exposure to an investigational device within 4 weeks prior to screening. Exposure to angiotensin-converting enzyme ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.